Company / Revenue
Prime Medicine, Inc. Revenue History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$3.0M
FY2024
5-year range
$0 / $5.2M
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#142 of 152
Health Care
What the data says
Among 152 Health Care companies, Prime Medicine, Inc. is in the bottom 7% for revenue. Improved from $0 to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2024.
Improved from $0 to $3M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 152This company $3.0M Sector average $4.5B
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #142 out of 152 companies in the Health Care sector.
- Peak revenue was recorded in FY2020.
- Lowest revenue in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.0M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $5.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026